BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer

• Hifzur Rahman Siddique,

  Affiliation Molecular Chemoprevention and Therapeutics, The Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America

  ⨯
• Aijaz Parray,

  Affiliation Molecular Chemoprevention and Therapeutics, The Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America

  ⨯
• Weixiong Zhong,

  Affiliation School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, United States of America

  ⨯
• R. Jeffery Karnes,

  Affiliation Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Eric J. Bergstralh,

  Affiliation Division of Biomedical Statistics and Informatics, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Shahriar Koochekpour,

  Affiliation Center for Genetics and Pharmacology, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Johng S. Rhim,

  Affiliation Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

  ⨯
• Badrinath R. Konety,

  Affiliation Department of Urology, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Mohammad Saleem

  * E-mail: msbhat@umn.edu

  Affiliations Molecular Chemoprevention and Therapeutics, The Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America, Department of Urology, University of Minnesota, Minneapolis, Minnesota, United States of America, Department of Laboratory Medicine Pathology, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯